91É«ÇéƬ
Back to
Mrs Kendal Chidwick

Mrs Kendal Chidwick

Postdoctoral Fellow

B.Pharm, MSc. Epidemiology, PhD candidate.

Medicine & Health
National Drug & Alcohol Research Centre

Kendal Chidwick is a pharmacoepidemiologist and PhD candidate at the National Drug and Alcohol Research Centre, 91É«ÇéƬ Sydney.  She is currently working on projects to synthesize the evidence on innovate approaches to service provision for the treatment of opioid use disorder, compare treatments for the acute management of opioid withdrawal, describe trends in the sales of opioid agonist treatment medicines, and the impact of the introduction of long-acting injectable buprenorphine.  Prior to this Kendal led the MedicineInsight Real World Research team at NPS MedicineWise and worked at the Clinical Practice Research Datalink (CPRD) at the MHRA. Kendal is a member of the Drug Utilisation Sub Committee (DUSC) of the Pharmaceutical Benefits Advisory Committee (PBAC).
Phone
+61 2 9348 1620
E-mail
k.chidwick@unsw.edu.au
Location
Remote working from Western Australia.
  • Journal articles | 2026
    Luong CHL; Kalisch Ellett L; Costa JDO; Chidwick K; Pratt N; Janetzki J, 2026, 'Impact of antiretroviral shortages in HIV therapy and prevention uptake in Australia', AIDS Care Psychological and Socio Medical Aspects of AIDS HIV, 38, pp. 789 - 799,
    Journal articles | 2025
    Chidwick K; Bharat C; Gisev N; Havard A; Camacho X; Pearson SA; Degenhardt L, 2025, 'Trends in prescription opioid analgesic use in Australia from 2015 to 2022', International Journal of Drug Policy, 135,
    Journal articles | 2024
    Bharat C; Chidwick K; Gisev N; Farrell M; Ali R; Degenhardt L, 2024, 'Trends in use of medicines for opioid agonist treatment in Australia, 2013–2022', International Journal of Drug Policy, 123,
    Journal articles | 2024
    Gillies MB; Chidwick K; Bharat C; Camacho X; Currow D; Gisev N; Degenhardt L; Pearson SA, 2024, 'Long-term prescribed opioid use after hospitalization or emergency department presentation among opioid naïve adults (2014–2020)—A population-based descriptive cohort study', British Journal of Clinical Pharmacology, 90, pp. 2111 - 2123,
    Journal articles | 2023
    Ahmed S; Pollack A; Havard A; Pearson SA; Chidwick K, 2023, 'Agreement of acute serious events recorded across datasets using linked Australian general practice, hospital, emergency department and death data: implications for research and surveillance', International Journal of Population Data Science, 8,
    Journal articles | 2022
    Chidwick K; Myton R; Rodgers A; Jun M; Dartnell J; Balcomb A; Dore G, 2022, 'A cluster randomized controlled trial of a MedicineInsight Educational Quality Improvement Programme to improve the diagnosis and treatment of chronic hepatitis C in general practice (the EQUIP-HEPC trial)', Journal of Viral Hepatitis, 29, pp. 135 - 146,
    Journal articles | 2022
    Chidwick K; Pollack A; Busingye D; Norman S; Grulich A; Bavinton B; Guy R; Medland N, 2022, 'Utilisation of pre-exposure prophylaxis (PrEP) for HIV prevention in the Australian general practice setting: a longitudinal observational study', Sexual Health, 19, pp. 101 - 111,
    Journal articles | 2022
    Daniels B; Havard A; Myton R; Lee C; Chidwick K, 2022, 'Evaluating the accuracy of data extracted from electronic health records into MedicineInsight, a national Australian general practice database', International Journal of Population Data Science, 7,
    Journal articles | 2022
    Pollack A; Busingye D; Thistlethwaite J; Blogg S; Chidwick K, 2022, 'Characteristics of patients aged 50-74 years with a request for an immunochemical faecal occult blood test in the Australian general practice setting', Australian Health Review, 46, pp. 222 - 232,
    Journal articles | 2022
    2022, 'Evaluating the accuracy of data extracted from electronic health records into MedicineInsight, a national Australian general practice database', INTERNATIONAL JOURNAL OF POPULATION DATA SCIENCE (IJPDS), 7,
    Journal articles | 2021
    Belcher J; Myton R; Yoo J; Boville C; Chidwick K, 2021, 'Exploring the physical health of patients with severe or long-term mental illness using routinely collected general practice data from MedicineInsight', Australian Journal of General Practice, 50, pp. 944 - 951,
    Journal articles | 2021
    Busingye D; Chidwick K; Simpson V; Dartnell J; J Dore G; Balcomb A; Blogg S; Dore G, 2021, 'The changing characteristics of patients with chronic hepatitis C prescribed direct acting antiviral medicines in general practice since listing of the medicines on the Australian Pharmaceutical Benefits Scheme', Jgh Open, 5, pp. 813 - 819,
    Journal articles | 2021
    Busingye D; Daniels B; Brett J; Pollack A; Belcher J; Chidwick K; Blogg S, 2021, 'Patterns of real-world opioid prescribing in Australian general practice (2013-18)', Australian Journal of Primary Health, 27, pp. 416 - 424,
    Journal articles | 2021
    Busingye D; Pollack A; Chidwick K, 2021, 'Prevalence of inflammatory bowel disease in the Australian general practice population: A cross-sectional study', Plos One, 16, pp. e0252458,
    Journal articles | 2021
    Havard A; Manski-Nankervis JA; Thistlethwaite J; Daniels B; Myton R; Tu K; Chidwick K, 2021, 'Validity of algorithms for identifying five chronic conditions in MedicineInsight, an Australian national general practice database', BMC Health Services Research, 21, pp. 551,
    Journal articles | 2021
    Schaffer AL; Busingye D; Chidwick K; Brett J; Blogg S, 2021, 'Pregabalin prescribing patterns in Australian general practice, 2012–2018: a cross-sectional study', Bjgp Open, 5, pp. 1 - 10,
    Journal articles | 2021
    de Oliveira Costa J; Gianacas C; Beard F; González-Chica DA; Chidwick K; Osman R; MacIntyre CR; Havard A, 2021, 'Cumulative annual coverage of meningococcal B vaccination in Australian general practice for three at-risk groups, 2014 to 2019', Human Vaccines & Immunotherapeutics, pp. 1 - 10,
    Journal articles | 2020
    Chidwick K; Busingye D; Pollack A; Osman R; Yoo J; Blogg S; Rubel D; Smith S, 2020, 'Prevalence, incidence and management of atopic dermatitis in Australian general practice using routinely collected data from MedicineInsight', Australasian Journal of Dermatology, 61, pp. e319 - e327,
    Journal articles | 2020
    Totterdell J; Phillips A; Glover C; Chidwick K; Marsh J; Snelling T; Macartney K, 2020, 'Safety of live attenuated herpes zoster vaccine in adults 70–79 years: A self-controlled case series analysis using primary care data from Australia's MedicineInsight program', Vaccine, 38, pp. 3968 - 3979,
    Journal articles | 2019
    Busingye D; Gianacas C; Pollack A; Chidwick K; Merrifield A; Norman S; Mullin B; Hayhurst R; Blogg S; Havard A; Stocks N, 2019, 'Data Resource Profile: MedicineInsight, an Australian national primary health care database', International Journal of Epidemiology, 48, pp. 1741 - 1741,
    Journal articles | 2018
    Chidwick K; Kiss D; Gray R; Yoo J; Aufgang M; Zekry A, 2018, 'Insights into the management of chronic hepatitis C in primary care using MedicineInsight', Australian Journal of General Practice, 47, pp. 639 - 645,
    Journal articles | 2018
    Chidwick K; Strongman H; Matthews A; Stanway S; Lyon AR; Smeeth L; Bhaskaran K, 2018, 'Statin use in cancer survivors versus the general population: Cohort study using primary care data from the UK clinical practice research datalink', BMC Cancer, 18, pp. 1018,
    Journal articles | 2014
    Illingworth PJ; Lahoud R; Quinn F; Chidwick K; Wilkinson C; Sacks G, 2014, 'Single-arm, observational study of the ease of use of a redesigned pen device to deliver recombinant human follicle-stimulating hormone (follitropin alfa) for assisted reproductive technology treatment', Patient Preference and Adherence, 8, pp. 813 - 826,
  • Conference Papers | 2024
    Bharat C; Stehlik P; Camacho X; Chidwick K; Daniels B; Gillies MB; Hansford H; Ho JN; Lin J; Lopez D; Kelly T-L; Kelty E; Noghrehchi F; Varney B; Filion KB; Pratt N, 2024, 'The Use and Implementation of Instrumental Variables in Pharmacoepidemiology: A Scoping Review', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY, pp. 618 - 618
    Conference Posters | 2024
    Chidwick K, 2024, 'Long-term prescribed opioid use after hospitalisation or emergency department presentation among opioid-naïve adults in New South Wales (NSW), Australia (2014–2020)—a population-based cohort study', Wesley Conference Centre, Sydney NSW, presented at 2024 NDARC Annual Research Symposium, Wesley Conference Centre, Sydney NSW, 20 September 2024
    Conference Presentations | 2024
    Chidwick K, 2024, 'Trends in prescription opioid analgesic use in Australia from 2015 to 2022: a national analysis using pharmaceutical claims and sales data', presented at 2024 NDARC Annual Research Symposium, Wesley Conference Centre, Sydney NSW, 20 September 2024,
    Conference Papers | 2023
    Bharat C; Chidwick K; Gisev N; Farrell M; Degenhardt L, 2023, 'National trends in the Australian opioid agonist treatment program, 2013 to 2022', in DRUG AND ALCOHOL REVIEW, WILEY, pp. S40 - S40
    Reports | 2023
    Bharat C; Chidwick K; Gisev N; Farrell M; Degenhardt L, 2023, NDARC Technical Report: Trends in the use of Opioid Agonist Treatment in New South Wales, 2013-2022, 91É«ÇéƬ Sydney, Sydney, 347, ,
    Reports | 2023
    Bharat C; Chidwick K; Gisev N; Farrell M; Degenhardt L, 2023, NDARC Technical Report: Trends in the use of Opioid Agonist Treatment in Queensland, 2013-2022, 91É«ÇéƬ Sydney, Sydney, 349, ,
    Reports | 2023
    Bharat C; Chidwick K; Gisev N; Farrell M; Degenhardt L, 2023, NDARC Technical Report: Trends in the use of Opioid Agonist Treatment in the Australian Capital Territory, 2013-2022, 91É«ÇéƬ Sydney; NDARC, Sydney, 346, ,
    Reports | 2023
    Bharat C; Chidwick K; Gisev N; Farrell M; Degenhardt L, 2023, NDARC Technical Report: Trends in the use of Opioid Agonist Treatment in the Northern Territory, 2013-2022, 91É«ÇéƬ Sydney, Sydney, 348, ,
    Reports | 2023
    Chidwick K; Bharat C; Gisev N; Farrell M; Degenhardt L, 2023, NDARC Technical Report: Real-world dosing intervals of long-acting buprenorphine for opioid agonist treatment., 91É«ÇéƬ Sydney, Sydney, 345, ,
    Reports | 2023
    Chidwick K; Gisev N; Degenhardt L; Farrell M; Bharat C, 2023, NDARC Technical Report: Trends in the use of Opioid Agonist Treatment in South Australia, 2013-2022, 91É«ÇéƬ Sydney, Sydney, 350, ,
    Reports | 2023
    Chidwick K; Gisev N; Degenhardt L; Farrell M; Bharat C, 2023, NDARC Technical Report: Trends in the use of Opioid Agonist Treatment in Tasmania, 2013-2022, 91É«ÇéƬ Sydney; National Drug and Alcohol Research Centre, Sydney, 351, ,
    Reports | 2023
    Chidwick K; Gisev N; Degenhardt L; Farrell M; Bharat C, 2023, NDARC Technical Report: Trends in the use of Opioid Agonist Treatment in Victoria, 2013-2022, 91É«ÇéƬ Sydney; National Drug and Alcohol Research Centre, Sydney, 352, ,
    Reports | 2023
    Chidwick K; Gisev N; Degenhardt L; Farrell M; Bharat C, 2023, NDARC Technical Report: Trends in the use of Opioid Agonist Treatment in Western Australia, 2013-2022, 91É«ÇéƬ Sydney; National Drug and Alcohol Research Centre, Sydney, 353, ,
    Conference Papers | 2021
    Havard A; Chidwick K; Daniels B; Thistlethwaite J; Myton R; Blogg S; Wall M; Quick L; Pollack A; Manski-Nankervis J-A, 2021, 'Validity of algorithms for identifying five chronic conditions in MedicineInsight, Australian national primary care data', in INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, OXFORD UNIV PRESS, ELECTR NETWORK, presented at World Congress of Epidemiology of the International-Epidemiological-Association (IEA), ELECTR NETWORK, 03 September 2021 - 06 September 2021,